Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-01-23
DOI
10.3389/fphar.2019.00001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- OUP accepted manuscript
- (2018) BRIEFINGS IN BIOINFORMATICS
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- Molecular pathway activation – New type of biomarkers for tumor morphology and personalized selection of target drugs
- (2018) Anton Buzdin et al. SEMINARS IN CANCER BIOLOGY
- Clinical development of mTor inhibitors for renal cancer
- (2017) Michele Ghidini et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- DGIdb 3.0: a redesign and expansion of the drug–gene interaction database
- (2017) Kelsy C Cotto et al. NUCLEIC ACIDS RESEARCH
- HMDB 4.0: the human metabolome database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- Temporary portal vein embolization is as efficient as permanent portal vein embolization in mice
- (2017) Andrea Wirsching et al. SURGERY
- A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information
- (2017) Yunan Luo et al. Nature Communications
- Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas
- (2017) Ivan Petrov et al. Oncotarget
- Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors
- (2017) Pavel Spirin et al. Oncotarget
- Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiation
- (2017) Maxim Sorokin et al. Oncotarget
- COSMIC: somatic cancer genetics at high-resolution
- (2016) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development
- (2016) Ivan V. Ozerov et al. Nature Communications
- Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
- (2015) Saїd Azoury et al. CURRENT CANCER DRUG TARGETS
- Disialoganglioside GD2 as a therapeutic target for human diseases
- (2015) Maya Suzuki et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
- (2015) Katarzyna Tomczak et al. Wspolczesna Onkologia-Contemporary Oncology
- A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation
- (2015) Artem Artemov et al. Oncotarget
- Signaling pathways activation profiles make better markers of cancer than expression of individual genes
- (2015) Nikolay M. Borisov et al. Oncotarget
- Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
- (2014) J. Oldenburg et al. ANNALS OF ONCOLOGY
- PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
- (2014) HaiXia Li et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Towards identification of true cancer biomarkers
- (2014) Eleftherios P Diamandis BMC Medicine
- Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial
- (2014) C Le Tourneau et al. BRITISH JOURNAL OF CANCER
- Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review)
- (2014) PAUL TOREN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Testicular Cancer: A Reflection on 50 Years of Discovery
- (2014) Nasser Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data
- (2014) Anton A. Buzdin et al. Frontiers in Genetics
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Targeted cancer therapy – Are the days of systemic chemotherapy numbered?
- (2013) Won Duk Joo et al. MATURITAS
- Target identification and mechanism of action in chemical biology and drug discovery
- (2013) Monica Schenone et al. Nature Chemical Biology
- DrugBank 4.0: shedding new light on drug metabolism
- (2013) Vivian Law et al. NUCLEIC ACIDS RESEARCH
- The Reactome pathway knowledgebase
- (2013) David Croft et al. NUCLEIC ACIDS RESEARCH
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- (2012) Alexei F. Kisselev et al. CHEMISTRY & BIOLOGY
- CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
- (2012) P. A. Prieto et al. CLINICAL CANCER RESEARCH
- Explaining the Unexplainable: EGFR Antibodies in Colorectal Cancer
- (2012) Axel Grothey et al. JOURNAL OF CLINICAL ONCOLOGY
- Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges
- (2012) Purvesh Khatri et al. PLoS Computational Biology
- Analysis of pathway mutation profiles highlights collaboration between cancer-associated superpathways
- (2011) Yunyan Gu et al. HUMAN MUTATION
- Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence
- (2011) C. Gridelli et al. LUNG CANCER
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
- (2011) Q. Ma et al. PHARMACOLOGICAL REVIEWS
- Vascular endothelial growth factor-targeted therapy in metastatic renal cell carcinoma
- (2010) Brian I. Rini CANCER
- Poly(ADP-Ribose) Polymerase Inhibition: "Targeted" Therapy for Triple-Negative Breast Cancer
- (2010) C. K. Anders et al. CLINICAL CANCER RESEARCH
- GeneCards Version 3: the human gene integrator
- (2010) M. Safran et al. Database-The Journal of Biological Databases and Curation
- A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas
- (2008) Kartik M Mani et al. Molecular Systems Biology
- PID: the Pathway Interaction Database
- (2008) Carl F. Schaefer et al. NUCLEIC ACIDS RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started